Delivery Order SPE2DB20D2104-SPE2DB24FQ65V

Award Date 10/10/23
Potential Completion Date 10/31/23
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for the supply of INGREZZA 80 MG CAPSULE 30S, a medication. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 Firm Fixed Price Delivery Order contract is for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a medication. The contract has an ultimate completion date of March 13, 2025 and was awarded on February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,893.15 firm-fixed-price Delivery Order is for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,239.10 Firm Fixed Price Delivery Order contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of February 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,049.61 firm fixed-price delivery order is for the supply of INGREZZA 60 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of April 21, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,239.10 Firm Fixed Price Delivery Order is for the supply of Ingrezza 40 mg capsules and has an ultimate completion date of September 1, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a delivery order worth $3,893.15 for the supply of INGREZZA 80 MG CAPSULE 30S, a specialty medication. The award has an ultimate completion date of October 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,119.55, is for the delivery of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of February 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,914.32 firm fixed-price delivery order is for the supply of INGREZZA 60 MG CAPSULE 30S, a specialty medication. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FQ65V
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,239.10 firm fixed-price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of October 31, 2023.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with a set-aside requirement, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 2/27/25, 10:11 AM